Fig. 2From: Impact of atherosclerotic cardiovascular disease on healthcare resource utilization and costs in patients with type 2 diabetes mellitus in a real-world settingASCVDa prevalence in a real-world T2DM population in the US in 2015 by age group. Footnotes: ASCVD Atherosclerotic cardiovascular disease, T2DM Type 2 diabetes mellitus. aAs defined by ADA 2017 guidelinesBack to article page